DaVita Q2 FY25: where the revenue came from and where it went
The whole income statement of DaVita for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Apr 1 – Jun 30, 2025
- Reported
- Aug 5, 2025
Revenue$3.38B
+6% year over year
Gross profit$0.95B
28% margin
Operating profit$0.54B
16% margin
Net profit$0.20B
6% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 3.38 | 100% | +6% |
| U.S.Dialysis & related lab | 2.90 | 86% | +2% |
| All other | 0.48 | 14% | +35% |
| Cost of revenue | −2.43 | 72% | |
| Gross profit | 0.95 | 28% margin | +1pp |
| G&A | −0.41 | 12% | +1pp |
| Operating profit | 0.54 | 16% margin | +0pp |
| Interest & other costs | −0.25 | ||
| Tax | −0.09 | ||
| Net profit | 0.20 | 6% margin | −1pp |
151 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest